Immunomonitoring reveals interruption of anergy after vaccination in a case of type-2-papillary renal cell carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunomonitoring reveals interruption of anergy after vaccination in a case of type-2-papillary renal cell carcinoma
Authors
Keywords
-
Journal
Immunotherapy
Volume 9, Issue 4, Pages 319-329
Publisher
Future Medicine Ltd
Online
2017-03-17
DOI
10.2217/imt-2016-0145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cells
- (2016) Mariana Pereira Pinho et al. CYTOTHERAPY
- Learning from PD-1 Resistance: New Combination Strategies
- (2016) Xia Bu et al. TRENDS IN MOLECULAR MEDICINE
- Immune DNA signature of T-cell infiltration in breast tumor exomes
- (2016) Eric Levy et al. Scientific Reports
- Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation
- (2015) T A Seldon et al. LEUKEMIA
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment
- (2015) Thomas F. Gajewski SEMINARS IN ONCOLOGY
- Immune monitoring technology primer: immunosequencing
- (2015) Ilan Kirsch Journal for ImmunoTherapy of Cancer
- Classification of current anticancer immunotherapies
- (2015) Lorenzo Galluzzi et al. Oncotarget
- Monocyte-derived dendritic cells reflect the immune functional status of a chromophobe renal cell carcinoma patient: Could it be a general phenomenon?
- (2014) Maria A. Clavijo-Salomon et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Sequential immune monitoring in patients with melanoma and renal cell carcinoma treated with high-dose interleukin-2: immune patterns and correlation with outcome
- (2014) David M. Foureau et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- SEOM clinical guidelines for the treatment of renal cell carcinoma
- (2014) J. Bellmunt et al. Clinical & Translational Oncology
- Renal cell carcinoma
- (2014) Daniel Su et al. CURRENT OPINION IN ONCOLOGY
- Dendritic cell membrane CD83 enhances immune responses by boosting intracellular calcium release in T lymphocytes
- (2014) Mariana Pereira Pinho et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Molecular Pathways: Fumarate Hydratase-Deficient Kidney Cancer--Targeting the Warburg Effect in Cancer
- (2013) W. M. Linehan et al. CLINICAL CANCER RESEARCH
- Predictive immunomonitoring — The COST ENTIRE initiative
- (2013) Dusan Popadic et al. CLINICAL IMMUNOLOGY
- Dendritic-Cell-Based Therapeutic Cancer Vaccines
- (2013) Karolina Palucka et al. IMMUNITY
- Are dysfunctional monocyte-derived dendritic cells in cancer an explanation for cancer vaccine failures?
- (2013) José Alexandre Marzagão Barbuto Immunotherapy
- Role of vaccine therapy for renal cell carcinoma in the era of targeted therapy
- (2013) Kazuhiro Yoshimura et al. INTERNATIONAL JOURNAL OF UROLOGY
- Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy
- (2013) Minoru Kobayashi et al. MEDICAL ONCOLOGY
- Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression
- (2013) Tomoyuki Yamaguchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Assessing T-cell responses in anticancer immunotherapy
- (2013) David Escors et al. OncoImmunology
- Decisions About Dendritic Cells: Past, Present, and Future
- (2012) Ralph M. Steinman Annual Review of Immunology
- Monocyte-derived dendritic cells from breast cancer patients are biased to induce CD4+CD25+Foxp3+ regulatory T cells
- (2012) R. N. Ramos et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Gene Expression Profile of Peripheral Blood Lymphocytes from Renal Cell Carcinoma Patients Treated with IL-2, Interferon-α and Dendritic Cell Vaccine
- (2012) Benita Wolf et al. PLoS One
- ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials
- (2012) Anatoli M. Malyguine et al. Cells
- Monocyte-derived DC maturation strategies and related pathways: a transcriptional view
- (2011) Luciano Castiello et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunologic Monitoring of Cellular Responses by Dendritic/Tumor Cell Fusion Vaccines
- (2011) Shigeo Koido et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments
- (2010) D. Busse et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cells
- (2008) Amy E. Anderson et al. JOURNAL OF LEUKOCYTE BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started